How can clinicians monitor and manage hematologic toxicities in patients with breast cancer receiving ADC therapy? In this video, Tajuana Bradley, MS, FNP-BC, and Abbey J. Kaler, MS, APRN, FNP-C, discuss practical approaches to laboratory monitoring and the assessment and management of neutropenia, thrombocytopenia, and anemia, including toxicity grading, treatment modifications, and patient education on symptoms that should be reported promptly.
Download Infographic
August 2026 | Volume 19 | No 3
To sign up for our newsletter or print publications, please enter your contact information below.
